Table 2.
mRNA | Non‐HRMG | CDO1 (HRMG) | |
---|---|---|---|
Sample stability | △ | 〇 | 〇 |
Sensitivity | 23% | 25% | 20% |
% of CY0 | 10% | 7%‐20% | 10% |
% of CY1 | 69% | 75% | 100% |
Marker | CEA | BNIP3/CHFR/CYP1B1/MINT25/SFRP2/RASSF2 | CDO1 |
Reference | 66 | 67 | 36 |
HRMG, highly relevant methylation gene.